Strategy purchased 24,869 Bitcoin for about $2.01 billion between May 11 and May 17, increasing its total Bitcoin holdings to 843,738 BTC, which is over 4% of Bitcoin's fixed supply. The purchase was funded by selling shares of its common stock (MSTR) and preferred stock (STRC). Despite Bitcoin prices falling below $77,000 due to ETF outflows and liquidations, Strategy continues to be a long-term net buyer, spending roughly $63.87 billion on Bitcoin at an average price of $75,700 per coin. The company also faces funding challenges, including repurchasing convertible notes, with potential funding sources including cash, stock sales, or Bitcoin sales.
Rein Therapeutics completed a $57.5 million underwritten public offering by selling 57.5 million shares at $1.00 each, including the full exercise of an over-allotment option. The proceeds will fund the Phase 2 clinical trial of their drug LTI-03 for...
Streamex Corp. announced its second monthly yield distribution for GLDY, a gold-backed tokenized security, covering April 2026. The yield is generated through Streamex's institutional gold leasing program, which currently earns an annualized lease yi...
TOYO Co., Ltd announced a 177% increase in Q1 2026 revenue to $142.8 million, driven by higher solar cell and module sales. Net income rose to $28.4 million from a loss of $3.7 million in Q1 2025, with EBITDA improving significantly. The company reaf...
IREN Limited has acquired Awaken, a creative and media agency, to strengthen its brand awareness and marketing as it expands globally. Awaken, previously IREN's external marketing partner, will now operate in-house with key team members, including CE...
Sitryx Therapeutics, a clinical-stage biopharmaceutical company focused on autoimmune and inflammatory diseases, announced its management will participate in three key investor conferences in June 2026: Jefferies Global Healthcare Conference in New Y...
